Psychotropic drugs and medical conditions /

Saved in:
Bibliographic Details
Imprint:New York : Nova Biomedical, [2017]
Description:1 online resource
Language:English
Series:Psychiatry, theory, applications and treatments
Psychiatry- theory, applications, and treatments series.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11677364
Hidden Bibliographic Details
Other authors / contributors:Uguz, Faruk, editor.
ISBN:9781536119589
153611958X
9781536119381
Notes:Includes bibliographical references and index.
Online resource; title from PDF title page (EBSCO, viewed June 27, 2017)

MARC

LEADER 00000cam a2200000Ii 4500
001 11677364
005 20210426223633.6
006 m o d
007 cr cnu|||unuuu
008 170626s2017 nyu ob 001 0 eng d
020 |a 9781536119589  |q (electronic bk.) 
020 |a 153611958X  |q (electronic bk.) 
020 |z 9781536119381 
035 |a (OCoLC)991595808 
035 9 |a (OCLCCM-CC)991595808 
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d EBLCP  |d OCLCF  |d AGLDB  |d IGB  |d AUW  |d BTN  |d MHW  |d INTCL  |d SNK  |d YDX  |d G3B  |d S8I  |d S8J  |d STF  |d D6H  |d N$T  |d OCLCQ 
049 |a MAIN 
050 4 |a RM315 
072 7 |a MED  |x 105020  |2 bisacsh 
245 0 0 |a Psychotropic drugs and medical conditions /  |c Faruk Uguz, editor. 
264 1 |a New York :  |b Nova Biomedical,  |c [2017] 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Psychiatry, theory, applications and treatments 
504 |a Includes bibliographical references and index. 
588 0 |a Online resource; title from PDF title page (EBSCO, viewed June 27, 2017) 
505 0 |a Preface; Acknowledgments; Chapter 1; Hematological Effects of Psychotropic Medications; Abstract; Introduction; Antipsychotic Medications; Second Generation Antipsychotic Drugs; Clozapine; Olanzapine; Risperidone and Paliperidone: Short-Acting and Long-Acting; Quetiapine; Ziprasidone; Aripiprazole; Iloperidone, Asenapine, and Lurasidone; First Generation Antipsychotic Drugs; Phenothiazines; Butyrophenones; Mood Stabilizer Medications; Carbamazepine; Oxcarbazepine; Divalproex; Lamotrigine; Lithium; Gabapentin; Pregabalin; Topiramate; Antidepressant Drugs 
505 8 |a Selective Serotonin Reuptake InhibitorsBupropion; Selective Serotonin Norepinephrine Reuptake Inhibitors; Atypical Antidepressants; Tricyclic and Tetracyclic Antidepressants; Benzodiazepines; Buspirone; Management; Conclusion; References; Chapter 2; Psychotropic Drug-Induced Renal Toxicity and Electrolyte Imbalance; Abstract; Introduction; Role of Kidneys in Drug Metabolism and Homeostasis; Psychotropics Known to Cause Renal Impairment and Electrolyte Imbalance; Psychotropics Causing Renal Toxicity; Lithium; Reduced Urinary Concentrating Capacity; Effect on Glomerular Filtration Rate 
505 8 |a Development of Nephrogenic Diabetes Insipidus (NDI)Other Renal Effects of Lithium; Antidepressants; Antipsychotics; Psychotropics Causing Electrolyte Imbalance; Psychotropic-Induced Hyponatremia (Table 3); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hypernatremia (Table 4); Psychotropic-Induced Hypokalemia (Table 4); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hyperkalemia (Table 4); Psychotropic-Induced Hypocalcemia (Table 4); Psychotropic-Induced Hypercalcemia (Table 4) 
505 8 |a Risk Factors of Psychotropic Induced Renal Impairment and Electrolyte ImbalanceAge; Gender; Physical Health and Co-Morbid Physical Illness; History of Hyponatremia/Electrolyte Disturbances in the Past; Nature of Psychiatry Disorder; Use of Other Concomitant Medications; Dose of Psychotropic Drug Used; Duration of Treatment; How to Prevent?; Psychotropic-Induced Renal Impairment; Psychotropic-induced Electrolyte Imbalance; Management; Management of Psychotropic-induced Renal Impairment Due to Rhabdomyolysis; Management of Lithium-induced Nephrogenic Diabetes Insipidus (NDI) 
505 8 |a Management of Lithium-Induced NephropathyTreatment of Lithium Toxicity and When to Go for Dialysis?; Psychotropic-Induced Electrolyte Imbalances; Hyponatremia; Management of Other Psychotropic-induced Electrolyte Imbalances; Conclusion; References; Chapter 3; Psychotropic Drug-Induced Hepatotoxicity; Abstract; Introduction; Antidepressants; Monoamine Oxidase (MAO) Inhibitors; Tricyclic Antidepressants; Selective Serotonin Reuptake Inhibitors; Serotonin Noradrenaline Reuptake Inhibitors; New Generation Antidepressants; Antipsychotic Agents; First Generation Antipsychotics (FGAs) 
650 0 |a Psychotropic drugs.  |0 http://id.loc.gov/authorities/subjects/sh85108528 
650 7 |a MEDICAL  |x Psychiatry  |x Psychopharmacology.  |2 bisacsh 
650 7 |a Psychotropic drugs.  |2 fast  |0 (OCoLC)fst01081826 
655 4 |a Electronic books. 
700 1 |a Uguz, Faruk,  |e editor. 
830 0 |a Psychiatry- theory, applications, and treatments series.  |0 http://id.loc.gov/authorities/names/n2009185501 
903 |a HeVa 
929 |a oclccm 
999 f f |i 0e352552-c504-5b97-ad1a-1966b6dd1679  |s c7340c38-8f47-5cf9-b8c5-7340158a11ae 
928 |t Library of Congress classification  |a RM315  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1540037  |z eBooks on EBSCOhost  |g ebooks  |i 12454106